| Michael A Sirr, MD | |
|
2475 E Broadway St, Helena, MT 59601-4928 | |
| (406) 442-2480 | |
| Not Available |
| Full Name | Michael A Sirr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 2475 E Broadway St, Helena, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053358622 | NPI | - | NPPES |
| 105162 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 6040 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael A Sirr, MD Po Box 5270, Norman, OK 73070-5270 Ph: (866) 321-8433 | Michael A Sirr, MD 2475 E Broadway St, Helena, MT 59601-4928 Ph: (406) 442-2480 |
News Archive
Medco Health Solutions, Inc. today announced new offerings within its Advanced Oncology Solutions, that include treatment pathways decision support with embedded pharmacogenomic testing and nutrition recommendations for cancer patients.
Tensys Medical, Inc., a leader in the development and commercialization of continuous, non-invasive hemodynamic patient monitoring systems, announced that a scientific paper evaluating the use of the company's T-line technology has been published in the British Journal of Anesthesia (03/13/13—advance online publication).
In four different studies presented at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC, researchers explored the effectiveness of probiotics for antibiotic-associated diarrhea; as an anti-inflammatory agent for patients with ulcerative colitis, psoriasis and chronic fatigue syndrome; and for people with abdominal discomfort and bloating who have not been diagnosed with a functional bowel disorder, such as irritable bowel syndrome (IBS).
MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.
› Verified 9 days ago
David W Silk, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-442-2480 | |
Andrew C Michel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-442-2480 | |
Mark Bryan Rabold, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-442-2480 | |
Mark S Ibsen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 39 Neill Ave, Helena, MT 59601 Phone: 406-513-1052 | |
Trent S. Jensen, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-444-2150 Fax: 406-447-2995 | |
William S Gallea, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-442-2480 |